Shuyi Song

411 citations
15 papers · 149 indexed · h-index 8
Topics
SARS-CoV-2 and COVID-19 Research (6 papers)COVID-19 Clinical Research Studies (4 papers)vaccines and immunoinformatics approaches (3 papers)
Partner nations
ChinaSingaporeJapan

In The Last Decade

Shuyi Song

13 papers receiving 148 citations

Peers

Shuyi Song
Comparison fields: 5 of 65
  • Infectious Diseases 77
  • Molecular Biology 55
  • Epidemiology 15
  • Immunology 15
  • Radiology, Nuclear Medicine and Imaging 12
Replace Tatjana Weil with:
Tatjana Weil Germany
Courtney J. Mycroft‐West United Kingdom
Lukas Wettstein Germany
Jinxiu Yao China
Kathy Stephens United States
Mohamed Imran India
Shea A. Lowery United States
Stephen Adonai Leon‐Icaza France
Agatha Treveil United Kingdom
Hangtian Guo China
Shuyi Song relative to Tatjana Weil Germany Tatjana Weil's profile →
Citations per field
00.5×1.5×2.4×
Tatjana Weil · 1×
Citations per year

Countries citing papers authored by Shuyi Song

Since Specialization
Citations

This map shows the geographic impact of Shuyi Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuyi Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuyi Song more than expected).

Fields of papers citing papers by Shuyi Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuyi Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuyi Song. The network helps show where Shuyi Song may publish in the future.

Co-authorship network of co-authors of Shuyi Song

This figure shows the co-authorship network connecting the top 25 collaborators of Shuyi Song. A scholar is included among the top collaborators of Shuyi Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuyi Song. Shuyi Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 4
3 9
4 0
5 3
6 10
7 29
8 41
9 8
10 8
11 6
12 16
13 7
14 7
15 1

About Shuyi Song

Shuyi Song is a scholar working on Infectious Diseases, Safety, Risk, Reliability and Quality and Immunology and Allergy, having authored 15 papers that have together received 149 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (4 papers) and vaccines and immunoinformatics approaches (3 papers). The work is most often cited by research in Infectious Diseases (77 citations), Animal Science and Zoology (10 citations) and Molecular Biology (55 citations). Shuyi Song has collaborated with scholars based in China, Singapore and Japan. Frequent co-authors include Aishun Jin, Feiyang Luo, Tingting Li, Ailong Huang, Rui‐Xin Wu, Yanan Hao, Song Mu, Yanfeng Gao, Guodong Li and Meiying Shen. Their work appears in journals such as Food Chemistry, Biochemical and Biophysical Research Communications and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026